GleamWall
中文EN

TGTX TG THERAPEUTICS, INC.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1001316 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY68.8%
TTM net income YoY-76.3%
TTM EPS YoY-75.8%
Revenue 3-yr CAGR67.9%
Net income 3-yr CAGR—

Margins

Gross margin82.7%
Operating margin21.5%
Net margin11.8%
FCF margin9.5%
EBITDA margin21.5%

Returns

ROE18.0%
ROA8.1%
ROIC (approx.)16.4%
Asset turnover0.69x

Leverage & solvency

Liabilities / assets64.1%
Debt / equity1.30x
Current ratio4.50x
Interest coverage4.14x

Cash quality & payout

Operating cash flow / net income0.81x
Accruals ratio1.5%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$616.29M$329.00M
Cost of revenue$100.71M$38.49M
Gross profit$515.57M$290.52M
R&D expense$160.22M$94.29M
SG&A expense$232.03M$154.30M
Operating income$123.32M$41.93M
Interest expense$26.73M$24.03M
Pretax income$107.39M$25.59M
Income tax-$339.79M$2.21M
Net income$447.18M$23.38M
EBITDA$123.38M$42.00M
EPS (basic)3.100.16
EPS (diluted)2.770.15
Weighted avg. shares (diluted)161.41M160.34M
Balance sheet
Cash & equivalents$79.15M$179.89M
Short-term investments$62.82M$131.11M
Receivables$305.63M$129.19M
Inventory$125.59M$110.46M
Current assets$630.76M$566.36M
Total assets$1.06B$577.69M
Current liabilities$153.76M$90.68M
Long-term debt$245.65M$244.43M
Total debt$245.65M$244.43M
Total liabilities$415.23M$355.33M
Shareholders' equity$648.02M$222.36M
Net debt$166.50M$64.53M
Shares outstanding155.31M155.84M
Cash flow statement
Operating cash flow-$24.77M-$40.52M
Capital expenditure$214,000$45,000
Free cash flow-$24.99M-$40.56M
Investing cash flow$13.80M-$1.04M
Financing cash flow-$89.73M$128.53M
Depreciation & amortization$59,000$68,000
Stock-based compensation$64.67M$42.54M

Free plan shows the latest 2 periods; Pro shows all 15 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.